Symptoms and Complications - Fatigue (79%) - Dry eyes (75%) - Dry mouth (73%) - Joint pain (65%) - Trouble sleeping (64%) - Increased rate of neonatal lupus erythematosus with congenital heart block requiring a pacemaker in pregnant women with anti-Ro/SS-A and anti-La/SS-B antibodies - Type I cryoglobulinemia - Affection of organs such as the liver, pancreas, kidneys, lungs, and central nervous system

Associated Conditions - Celiac disease - Fibromyalgia - Systemic lupus erythematosus (lupus) - Autoimmune thyroiditis - Multiple sclerosis and spondyloarthropathy - Several malignancies, principally non-Hodgkin lymphoma

Causes and Pathogenesis - Combination of genetics and an environmental trigger such as exposure to a virus or bacterium - Can occur independently (primary Sjögren's syndrome) or as a result of another connective tissue disorder (secondary Sjögren's syndrome) - Association with other autoimmune diseases such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), or systemic sclerosis - Lack of fully elucidated pathogenetic mechanisms - Immune system-mediated loss of exocrine glands - Infiltration of lymphocytes causing glandular dysfunction - Association with increased levels of IL-1RA in cerebrospinal fluid (CSF) - Interleukin 1 system involvement and cytokine-induced sickness behavior

Genetic Predisposition and Environmental Triggers - The major histocompatibility complex/human leukocyte antigen (MHC/HLA) region is significantly associated with primary Sjögren's syndrome. - A genome-wide association study identified six independent loci associated with primary Sjögren's syndrome. - These loci include IRF5, STAT4, BLK, IL12A, TNIP1, and CXCR5. - HLA-DR and HLA-DQ alleles are involved in the pathogenesis of Sjögren's syndrome. - HLA class II alleles are associated with specific subsets of autoantibodies. - Glandular viral infection can activate the innate immune system through toll-like receptors. - Epstein-Barr virus (EBV), human T-lymphotropic virus 1, and hepatitis C virus have been implicated in Sjögren's syndrome. - EBV reactivation is common in Sjögren's patients, indicating viral replication and immune response in target organs. - The exact mechanisms of EBV reactivation in Sjögren's lesions are not fully understood. - Other environmental factors may also contribute to the development of Sjögren's syndrome.

Autoantibodies and Epigenetic Abnormalities - Loss of B-cell tolerance leads to the production of autoantibodies. - Anti-SSA/Ro and anti-SSB/La antibodies are associated with Sjögren's syndrome. - Seropositivity for anti-Ro and anti-La antibodies is linked to greater disease severity and longer duration. - These antibodies are abundant in the salivary glands of Sjögren's patients. - Their role in the pathogenesis of Sjögren's syndrome is essential. - Epigenetic abnormalities may play a key role in the pathogenesis of autoimmune diseases, including Sjögren's syndrome. - DNA methylation, histone acetylation, and microRNA expression are potential epigenetic mechanisms involved. - Research in this area is limited. - Further studies are needed to understand the impact of epigenetic abnormalities on Sjögren's syndrome. - Targeting epigenetic modifications could be a potential therapeutic approach.

Ethnic Variations - Patients of different ethnic origins carry different HLA-susceptibility alleles. - HLA-DR and HLA-DQ alleles are involved in Sjögren's syndrome pathogenesis. - Northern and Western European and North American patients have a high prevalence of B8, DRw52, and DR3 genes. - HLA class II alleles are associated with specific subsets of autoantibodies. - Ethnic variations may contribute to differences in disease presentation and severity.